Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (731-740 of 915) with videos related to

Pageof 92
Sort By:
Frontiers in Immunology|December 9, 2022
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functionsAngela I Schriek, Marlies M van Haaren, Meliawati Poniman, et al.
Clinical and Vaccine Immunology : CVI|October 11, 2008
Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, TurkeyC K Porter, H El Mohammady, S Baqar, et al.
Vaccines|August 28, 2021
Changing Attitudes toward the COVID-19 Vaccine among North Carolina Participants in the COVID-19 Community Research PartnershipChukwunyelu H Enwezor, James E Peacock, Austin L Seals, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human PrimatesJennifer R Stapleton-Kotloski, Jared A Rowland, April T Davenport, et al.
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Iscience|May 6, 2024
A spike virosome vaccine induces pan-sarbecovirus antibody responses in miceMitch Brinkkemper, Meliawati Poniman, Esther Siteur-van Rijnstra, et al.
Retrovirology|April 29, 2014
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studiesNancy P Y Chung, Katie Matthews, Helen J Kim, et al.
The Journal of Bone and Joint Surgery. American Volume|August 9, 2005
Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-upEllen J MacKenzie, Michael J Bosse, Andrew N Pollak, et al.
Cell Reports|June 29, 2022
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association ratesMd Alamgir Hossain, Kara Anasti, Brian Watts, et al.
Pageof 92

Showing results (731-740 of 915) with videos related to

Sort By:
Pageof 92
Frontiers in Immunology|December 9, 2022
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functionsAngela I Schriek, Marlies M van Haaren, Meliawati Poniman, et al.
Clinical and Vaccine Immunology : CVI|October 11, 2008
Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, TurkeyC K Porter, H El Mohammady, S Baqar, et al.
Vaccines|August 28, 2021
Changing Attitudes toward the COVID-19 Vaccine among North Carolina Participants in the COVID-19 Community Research PartnershipChukwunyelu H Enwezor, James E Peacock, Austin L Seals, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human PrimatesJennifer R Stapleton-Kotloski, Jared A Rowland, April T Davenport, et al.
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Iscience|May 6, 2024
A spike virosome vaccine induces pan-sarbecovirus antibody responses in miceMitch Brinkkemper, Meliawati Poniman, Esther Siteur-van Rijnstra, et al.
Retrovirology|April 29, 2014
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studiesNancy P Y Chung, Katie Matthews, Helen J Kim, et al.
The Journal of Bone and Joint Surgery. American Volume|August 9, 2005
Long-term persistence of disability following severe lower-limb trauma. Results of a seven-year follow-upEllen J MacKenzie, Michael J Bosse, Andrew N Pollak, et al.
Cell Reports|June 29, 2022
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association ratesMd Alamgir Hossain, Kara Anasti, Brian Watts, et al.
Pageof 92